RT @wtrflea_papers: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice https://t.co/TAFzyP7Tgo
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
RT @Blagosklonny: @mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost…
@mkaeberlein Aging is quasi-programmed early in life and rapamycin slows down aging any time: early in life, on the cost of growth inhibition and late in life, without any costs https://t.co/cMAvF6nwFD
RT @wtrflea_papers: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice https://t.co/TAFzyP7Tgo
RT @Blagosklonny: Loss of GH signaling extends life in mice. But this loss must occur immediately after birth (first 8 weeks) thus making m…
RT @AgingBiology: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.c…
RT @TimePieChina: In https://t.co/d1XxNYOQPV Dr. @Blagosklonny shares a different view on when to start anti-aging with rapamycin, drawing…
RT @AgingBiology: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.c…
RT @AgingBiology: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.c…
RT @AgingBiology: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.c…
Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice https://t.co/TAFzyP7Tgo
RT @AgingBiology: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.c…
RT @AgingBiology: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.c…
RT @AgingBiology: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.c…
I will say the hypofunction theory is a reasonable theory for ageing, At least from the mTOR attenuation - anti-ageing perspective.
Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny https://t.co/YfnkByVrng
RT @TimePieChina: In https://t.co/d1XxNYOQPV Dr. @Blagosklonny shares a different view on when to start anti-aging with rapamycin, drawing…
Wow, this is interesting.
RT @TimePieChina: In https://t.co/d1XxNYOQPV Dr. @Blagosklonny shares a different view on when to start anti-aging with rapamycin, drawing…
RT @Blagosklonny: Loss of GH signaling extends life in mice. But this loss must occur immediately after birth (first 8 weeks) thus making m…
RT @TimePieChina: In https://t.co/d1XxNYOQPV Dr. @Blagosklonny shares a different view on when to start anti-aging with rapamycin, drawing…
RT @TimePieChina: In https://t.co/d1XxNYOQPV Dr. @Blagosklonny shares a different view on when to start anti-aging with rapamycin, drawing…
In https://t.co/d1XxNYOQPV Dr. @Blagosklonny shares a different view on when to start anti-aging with rapamycin, drawing attention to recent research on the limitations of early use of rapamycin (affecting growth and development,short-term interventions th
Loss of GH signaling extends life in mice. But this loss must occur immediately after birth (first 8 weeks) thus making mice dwarf. Later in life, loss of GH does not extend lifespan (see fig 1 and section on GH). https://t.co/Y7aCDPslNF
RT @healthspanmed: An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to…
RT @agingdoc1: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this ar…
RT @agingdoc1: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this ar…
RT @healthspanmed: An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to…
RT @agingdoc1: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this ar…
Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice | Aging https://t.co/tdnbZsYHsu @maximon_ag @longevity_inv @marcpbernegger @TobiasReichmuth @dr_roider @Dr_Bischof #longevity #lifespan #antiaging #health #sc
Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice - https://t.co/lIM9ImCjxm - #longevity
RT @agingdoc1: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this ar…
RT @RapamycinPress: At what age (and schedule) treatment with rapamycin may be started for maximal longevity in humans? https://t.co/RcFCo…
RT @healthspanmed: An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to…
RT @agingdoc1: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this ar…
RT @RapamycinPress: At what age (and schedule) treatment with rapamycin may be started for maximal longevity in humans? https://t.co/RcFCo…
RT @agingdoc1: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this ar…
https://t.co/9a9d3U29yf great article from @Blagosklonny . As someone in their 20's taking rapamycin it was a very interesting read.
RT @healthspanmed: An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to…
RT @Blagosklonny: See figure 3 (not figure 1)
RT @RapamycinPress: At what age (and schedule) treatment with rapamycin may be started for maximal longevity in humans? https://t.co/RcFCo…
RT @healthspanmed: An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to…
RT @healthspanmed: An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to…
RT @agingdoc1: Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this ar…
RT @healthspanmed: An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to…
An important article by @Blagosklonny discussing the appropriate age and dosing schedule that should be administered to maximize healthspan in humans: https://t.co/uVBFAvy7Hq
See figure 3 (not figure 1)
Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice @Blagosklonny "... this article attempts to reconcile conflicting results and suggests the optimal treatment strategy to extend human lifespan." https://t.co
At what age (and schedule) treatment with rapamycin may be started for maximal longevity in humans? https://t.co/RcFCo0hWME